SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-5,306 Cr | ₹-690 Cr | ₹-7,944 Cr | ₹-5,725 Cr | ₹536 Cr |
What is the latest Cash Flow from Investing Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-5,306 Cr |
| Mar2024 | ₹-690 Cr |
| Mar2023 | ₹-7,944 Cr |
| Mar2022 | ₹-5,725 Cr |
| Mar2021 | ₹536 Cr |
How is Cash Flow from Investing Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5,306 Cr | Negative | |
| Mar2024 | ₹-690 Cr | Negative | |
| Mar2023 | ₹-7,944 Cr | Negative | |
| Mar2022 | ₹-5,725 Cr | Negative | |
| Mar2021 | ₹536 Cr | - | |
Compare Cash Flow from Investing Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,030.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
| MANKIND PHARMA | ₹97,332.8 Cr | -0.6% | -5.9% | 0.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.8% |
-4.2% |
7% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses